Objectives. To develop a clinical prediction model enabling the calculation of an individual patient's life expectancy (LE) and survival probability based on age, sex, and comorbidity for use in the joint decision-making process regarding medical treatment.Methods.A computer software program was developed with a team of 3 clinicians, 2 professional actuaries, and 2 professional computer programmers. This incorporated statistical spreadsheet and database access design methods. Data sources included life insurance industry actuarial rating factor tables (public and private domain), Government Actuary Department UK life tables, professional actuarial sources, and evidence-based medical literature. The main outcome measures were numerical and graphical display of comorbidity-adjusted LE; 5-, 10-, and 15-year survival probability; in addition to generic UK population LE.Results.Nineteen medical conditions, which impacted significantly on LE in actuarial terms and were commonly encountered in clinical practice, were incorporated in the final model. Numerical and graphical representations of statistical predictions of LE and survival probability were successfully generated for patients with either no comorbidity or a combination of the 19 medical conditions included. Validation and testing, including actuarial peer review, confirmed consistency with the data sources utilized.Conclusions. The evidence-based actuarial data utilized in this computer program design represent a valuable resource for use in the clinical decision-making process, where an accurate objective assessment of patient LE can so often make the difference between patients being offered or denied medical and surgical treatment. Ongoing development to incorporate additional comorbidities and enable Web-based access will enhance its use further.
Wilson JR, Clarke MG, Ewings P., Graham JD, MacDonagh RPThe assessment of patient life expectancy: how accurate are urologists & oncologists? BJU Int. 2005;95(6):794-8.
2.
Walz J., Gallina A., Perrotte P., et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007;100(6):1254-8.
3.
Glare P., Virik K., Jones M., et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003;327:195.
4.
Alibhai SMH , Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G.Is there age bias in the treatment of localized prostate cancer? Cancer. 2004;100(1):72-81.
5.
Charlson ME, Pompei P., Ales KL, MacKenzie CRA new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Disease. 1987;40:373-83.
6.
Greenfield S. , Aronow HU, Elashoff RM, Watanabe D.Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA. 1988;260:2253-5.
7.
Linn BS, Linn MW, Gurel L.Cumulative illness rating scale. J Am Geriatr Soc . 1968;16(5):622-6.
8.
Kaplan MH, Feinstein ARThe importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27:387-404.
9.
Piccirillo JFWeb-based prognostigram. Available from: URL: http://oto.wustl.edu/clinepi/prog.html
10.
Charlson M., Szatrowski TP, Peterson J., Gold J.Validation of a combined comorbidity index. J Clin Epidemiol . 1994;47:1245-51.
11.
Post PN, Kil PJ, Hendrikx AJ, Janssen-Heijnen ML, Crommelin MA, Coebergh JWComorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int. 1999;84(6):652-6.
12.
Barry MJ, Albertsen PC, Bagshaw MA, et al. Outcomes for men with clinically non-metastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001;91:2302-14.
13.
Lloyd-Jones DM, Wilson PW, Larson MG, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol . 2004;94:20-4.
14.
Assmann G., Cullen P., Schulte H.The Munster Heart Study (PROCAM): results of follow-up at 8 years . Eur Heart J. 1998;19 Suppl A:A2-11.
15.
British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association.Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ. 2000;320:705-8.
16.
American Society of Anesthesiologists.New classification of physical status. Anesthesiology . 1963;24:111.
17.
Knaus WA, Draper EA, Wagner DP, Zimmerman JEAPACHE II: a severity of disease classification system. Crit Care Med. 1985; 13:818-29.
18.
Copeland GP , Jones D., Walters M.POSSUM: a scoring system for surgical audit . Br J Surg. 1991;78:355-60.
19.
Government Actuary's Department.Interim life tables. Available from: URL: http://www.gad.gov.uk/Demography_Data/Life_Tables/Interim_life_tables.asp
20.
Kita MWThe rating of substandard lives. In: Brackenridge RDC, Elder WJ, eds. Medical Selection of Life Risks. London: Macmillan Reference Ltd; 1998. p 61-88.
21.
The Actuarial Profession.Continuous mortality investigation. Available from: URL: http://www.actuaries.org.uk/knowledge/cmi
22.
Brackenridge RDC, Croxson RS, Mackenzie R.Medical Selection of Life Risks. 5th ed. Basingstoke (UK): Palgrave Macmillan ; 2006.
23.
Reilly BM, Evans ATTranslating clinical research into clinical practice: impact of using clinical prediction rules to make decisions. Ann Int Med. 2006;144:201-9.
24.
O'Connor AM , Bennett C., Stacey D., et al. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making. 2007;27:554-74.
25.
Edwards A., Elwyn G., Mulley A.Explaining risks: turning numerical data into meaningful pictures . BMJ. 2002;324:827-30.
26.
Lloyd A., Hayes P., Bell PR, Naylor ARThe role of risk and benefit perception in informed consent for surgery . Med Decis Making. 2001;21:141-9.
27.
Fuller R., Dudley N., Blacktop J.Risk communication and older people: understanding of probability and risk information by medical inpatients aged 75 years and older. Age Ageing. 2001; 30:473-6.
